Fifty-two ENS patients were randomly distributed in two equal groups: group
I was subjected to submucosal fat implant injection and group II was
subjected to submucosal fat implant with ADSCs injection.
Improvement was assessed using the SNOT-25 test, anterior rhinoscopy,
endoscopic examination, and the saccharin test. Evaluations were performed
preoperatively and at 1, 3, 6, 12, and 18 months after surgery. In addition,
a punch biopsy of turbinate tissue was analyzed histopathologically and by
RT-PCR to measure nasal expression of lysozyme and mucin-4.
Both groups showed significant improvement in SNOT-25 scores after surgery,
which persisted throughout the 18-month follow-up. Saccharin clearance times
improved in both groups. Histopathological examination revealed greater
regeneration of the mucosa and submucosa in the fat + ADSC group. RT-PCR
analysis showed strong expression of two key nasal mucosa markers, lysozyme
and MUC4, which support local immune defense and normal mucus production.